Core Viewpoint - A class action lawsuit has been filed against The Trade Desk, Inc. for allegedly misleading investors about its business prospects during a specific period [1][2]. Group 1: Allegations and Challenges - The lawsuit claims that The Trade Desk failed to disclose significant execution challenges related to the rollout of its new platform, Kokai, which affected client transitions from the older platform, Solimar [2]. - These execution challenges reportedly delayed the Kokai rollout and negatively impacted the company's business operations and revenue growth [2]. - The positive statements made by the company regarding its business and prospects were deemed materially false and misleading due to these undisclosed issues [2]. Group 2: Financial Performance - On February 12, 2025, The Trade Desk reported fourth quarter revenue of $741 million, which was below its guidance of $756 million and analysts' expectations of $759.8 million [3]. - The company's revenue guidance for the first quarter of 2025 was at least $575 million, missing analysts' estimates of $581.5 million [3]. - Following the announcement of these results and the acknowledgment of the slower Kokai rollout, the stock price dropped by $40.31, or over 32%, from $122.23 to $81.92 per share [3]. Group 3: Class Action Participation - Shareholders interested in participating in the class action must file their papers by April 21, 2025, to serve as lead plaintiffs [4]. - Shareholders can remain absent class members if they choose not to participate in the case [4]. Group 4: Company Background - Robbins LLP is noted as a leader in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired ModivCare, Inc. (NASDAQ: MODV) securities between November 3, 2022, and September 15, 2024, alleging that the company misled investors regarding its business prospects [1][2]. Allegations - The complaint states that ModivCare failed to disclose that certain contracts in its Non-Emergency Medical Transportation (NEMT) segment led to a deterioration in the company's free cash flow [2]. - As a result of these undisclosed issues, the company experienced negative impacts on adjusted EBITDA due to contract renegotiations and pricing accommodations, and it faced liquidity challenges [2][3]. - The positive statements made by the company regarding its business operations and prospects were deemed materially misleading and lacked a reasonable basis [2][3]. Legal Proceedings - Shareholders interested in serving as lead plaintiffs in the class action must file necessary documents with the court by March 31, 2025 [4]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [4]. Company Background - Robbins LLP is recognized for its leadership in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].

Core Viewpoint - A class action lawsuit has been filed against The Trade Desk, Inc. for allegedly misleading investors about its business prospects during a specific period, particularly regarding the rollout of its new platform, Kokai [1][2]. Group 1: Allegations and Challenges - The lawsuit claims that The Trade Desk failed to disclose significant execution challenges related to the Kokai rollout, which included difficulties in transitioning clients from the older platform, Solimar [2]. - These execution challenges reportedly delayed the Kokai rollout and negatively impacted the company's business operations and revenue growth [2]. - The positive statements made by the company regarding its business and prospects were deemed materially false and misleading due to these undisclosed challenges [2]. Group 2: Financial Performance - On February 12, 2025, The Trade Desk reported fourth quarter revenue of $741 million, which was below its guidance of $756 million and analysts' estimates of $759.8 million [3]. - The company's revenue guidance for the first quarter of 2025 was at least $575 million, missing analysts' expectations of $581.5 million [3]. - Following the announcement of these results and the acknowledgment of the slower Kokai rollout, the stock price dropped by $40.31, or over 32%, from $122.23 to $81.92 per share [3].